Sep 14, 2021

Featuring perspectives from Dr Karen A Gelmon, including the following topics:

• Management of Metastatic HER2-Positive Breast Cancer
  • Introduction (0:00)
  • Case: A woman in her late 60s with HER2-positive breast cancer with symptomatic brain metastases — Sulfi Ibrahim, MD (5:26)
  • Case: A woman in her late 30s with de novo ER-positive, HER2-positive breast cancer with brain metastases — Kelly Yap, MD (9:04)
  • Case: A woman in her early 70s with ER-positive, HER2-positive de novo metastatic breast cancer — Chris Prakash, MD (15:04)
  • Beyond the Guidelines (20:54)
• Localized HER2-Positive Breast Cancer
  • Case: A woman in her early 60s with localized weakly ER/PR-positive, HER2-positive breast cancer — Andrea Stebel, MD (37:00)
  • Case: A woman in her mid-50s with localized HER2-positive, node-positive breast cancer — Estelamari Rodriguez, MD, MPH (47:28)
  • Beyond the Guidelines (51:19)

CME information and select publications